Assays / Bloodborne infections
Bloodborne infections
Bloodborne Virus Panel — HBsAg, HIV-1/2 and HCV Multiplex Assay
A planned multiplex strip that screens for hepatitis B, HIV and hepatitis C in one run, read and recorded by the OncoFirm reader.
At a glance
Targets
HBsAg (antigen), antibodies to HIV-1/2 and HCV
Sample
Serum, plasma or fingerstick whole blood
Readout
Separate instrument-read result for each target
Status
Planned
Why it matters
Clinical context
Hepatitis B, HIV and hepatitis C share routes of transmission, so they are often screened together in antenatal care, blood-donor and harm-reduction settings. One sample and one run for all three saves time and reduces the chance of a missed test.
How OncoFirm will measure it
Built on the OncoFirm fluorescent platform
Three answers, one strip
The platform’s multiplex architecture is designed to report each target separately from a single sample.
A strip that checks itself
Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.
A traceable digital record
Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.
Where it's headed
Development roadmap
01
Feasibility
Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.
02
Assay development
Strip, reagents and reader settings are optimized, and pilot lots are built.
03
Analytical validation
Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.
04
Clinical evaluation and launch
Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.
Related assays
Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.
Partner on this assay
We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.